Step 1
Unite with Fellow Investors
Step 2
Choose the Best Attorney
Step 3
Provide Documents
Step 4
Follow Case Progress
Step 5
Get Payout
NEO.US
id: 1090
NeoGenomics (NEO) Patents’ Infringement and Federal Injunction Case
- On July 31, 2023, NeoGenomics’ (NEO) competitor announced that it had sued NeoGenomics in federal court for patents’ infringement, and on December 27, 2023, it announced that the federal court had issued an injunction.
- On it, $NEO fell 18,1%, losing $472M+ of shareholder value.
- Investors may have grounds to suspect NeoGenomics of patents’ infringement, which led to their losses.
On July 31, 2023, NeoGenomics’ competitor, Natera, announced that it had sued NeoGenomics in federal court, accusing the Company’s RaDaR test of infringing Natera’s patents.
Then, on December 27, 2023, Natera announced that the federal court had issued a preliminary injunction, effective immediately, barring NeoGenomics from making, using, selling, or promoting the RaDaR test.
On this news, $NEO fell 18,1% and lost over $472 million of its market capitalization, seriously damaging shareholders.
Considering all the information, investors might have grounds to suspect NeoGenomics of patents’ infringement with negative impact on the Company’s financial position, which led to their losses.
The case is already under investigation by at least one of the reputable law firms.
Case Status
Attorney Investigation
Alleged Offence
Misleading Statements,
Failure to Disclose,
Omissions
Suspected Party
Directors,
Management
Security Type
Stocks
Trade Direction
Long
Shock Event Date
28 December 2023